Viewing Study NCT07392320


Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-03-31 @ 12:06 PM
Study NCT ID: NCT07392320
Status: RECRUITING
Last Update Posted: 2026-02-06
First Post: 2026-01-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Trial Comparing Immunotherapy Versus Capecitabine Maintenance After Chemo-chemoradiotherapy for High-risk Nasopharyngeal Carcinoma
Sponsor: Sun Yat-sen University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module